CLINICAL_TRIALS
trial_result
· 2023-11-13
Clinical Trial Update: Treatment of POEMS Syndrome With Daratumumab [Phase 2]
Summary
Phase 2 clinical trial evaluating daratumumab for POEMS syndrome has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arkansas | Conditions: POEMS Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2023-11-13